FACTORS RELATED OF MOTOR-COGNITIVE DUAL-TASK INTERVENTION ON TREADMILL IN PARKINSON’S DISEASE PATIENTS AT THE NATIONAL GERIATRIC HOSPITAL

Hoang Bich Thuy1, Kim Anh Tung2, Phan Thi Kieu Loan3, Nguyen Hoai Nam3
1 Sun Group International Hospital
2 National Geriatric Hospital
3 Hanoi Medical University

Main Article Content

Abstract

Objectives: This study aims to evaluate the factors affecting the outcomes of dual-task cognitive-motor intervention on a treadmill in patients with Parkinson’s disease.


Subjects and methods: The study included 33 patients with Parkinson’s disease at the National Geriatric Hospital from January 2024 to September 2024. This was a non-controlled interventional study. Patients in the study group were examined and assessed, then guided to participate in a dual-task intervention program on a treadmill at the hospital under the supervision of doctors and technicians to ensure adherence to the training program.


Results: After the intervention, walking speed improved from 0.873 m/s to 0.903 m/s, and the 6-minute walking distance increased by an average of 25.83 ± 20.61 meters (p < 0.001). Significant improvements in motor function were notably higher in the following groups: those with a disease duration of 3 years or more (increased walking speed and reduced TUG time, p < 0.05); those with mild to moderate motor impairment (UPDRS III) (increased FGA scores, p = 0.032); those in early Hoehn and Yahr stages 1-2 (increased 6-minute walking distance, p = 0.017). The improvement in gait (FGA) showed a strong positive correlation with overall motor recovery (r = 0.81).


Conclution: Positive improvements were observed in patients with a disease duration of more than 3 years, lower Hoehn and Yahr stages, and mild to moderate motor impairment as measured by UPDRS III.

Article Details

References

[1] Balestrino R, Schapira A.H.V. Parkinson disease. Eur J Neurol, 2020, 27 (1): 27-42. doi: 10.1111/ene.14108.
[2] Li Z, Wang T et al. Dual-task training on gait, motor symptoms, and balance in patients with Parkinson’s disease: a systematic review and meta-analysis. Clin Rehabil, 2020, 34 (11): 1355-1367. doi: 10.1177/0269215520941142
[3] Raket L.L, Oudin Åström D et al. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease. Sci Rep, 2022, 12 (1): 526. doi: 10.1038/s41598-021-04356-8.
[4] Garcia Ruiz P.J, Luquin Piudo R et al. On disease modifying and neuroprotective treatments for Parkinson’s disease: physical exercise. Front Neurol, 2022, 13: 938686. doi: 10.3389/fneur.2022.938686.
[5] Bohnen N.I, Martin W.R.W. Dopamine-dependent functional connectivity in Parkinson disease: a resting-state diagnosis? Neurology, 2014, 83 (3): 202-203. doi: 10.1212/WNL.0000000000000599.
[6] Dahlberg L.S, Lungu O, Doyon J. Cerebellar contribution to motor and non-motor functions in Parkinson’s disease: a meta analysis of fMRI findings. Front Neurol, 2020, 11: 127. doi: 10.3389/fneur.2020.00127.
[7] Yang Y, Wang Y et al. Validity of the functional gait assessment in patients with Parkinson disease: construct, concurrent, and predictive validity. Phys Ther, 2014, 94 (3): 392-400. doi: 10.2522/ptj.20130019.
[8] Ivey F.M, Katzel L.I et al. The Unified Parkinson’s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function. J Rehabil Res Dev, 2012, 49 (8): 1269-1276. doi: 10.1682/jrrd.2011.06.0103.